The goal of geroscience is life extension

Mikhail V. Blagosklonny

doi:10.18632/oncotarget.27882

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Perspectives:

The goal of geroscience is life extension

Mikhail V. Blagosklonny _

PDF | Full Text | How to cite | Press Release | Podcast

Oncotarget. 2021; 12:131-144. https://doi.org/10.18632/oncotarget.27882

Metrics: PDF 2397 views | Full Text 21920 views | ?

Abstract

Mikhail V. Blagosklonny1

1 Roswell Park Cancer Institute, Buffalo, NY 14263, USA

Correspondence to:

Mikhail V. Blagosklonny,

email:

[email protected],
[email protected]

Keywords: aging; longevity; rapamycin; mTOR; metformin

Received: December 23, 2020 Accepted: January 13, 2021 Published: February 02, 2021

Copyright: © 2021 Blagosklonny. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

ABSTRACT

Although numerous drugs seemingly extend healthspan in mice, only a few extend lifespan in mice and only one does it consistently. Some of them, alone or in combination, can be used in humans, without further clinical trials.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27882

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Perspectives:

The goal of geroscience is life extension

Abstract